Heparin exhibits dual activity against malaria
A study by researchers from IBEC, ISGlobal and the University of Barcelona published in Nanomedicine opens the door to improved treatment of malaria with heparin.
Heparin (left) has been shown to have antimalarial activity and specific binding affinity for red blood cells infected with Plasmodium falciparum, versus non-infected blood cells. The study explores whether these properties could be exploited in a strategy based on the targeted delivery of antimalarial agents.